Custom Lentiviral shRNA Expression Construct, plasmid only
Custom shRNA Knockdown Constructs
Product Description
To make an lentiviral shRNA construct, we only need to know the RefSeq number. Cellecta typically designes and clones 3-5 constructs that target your transcript. The proprietary shRNA design delivers approximately 70% shRNAs that generate >70% transcript knockdown in standard cell lines as measured by qRT-PCR so it is likely that at least 2 of 3 or 3 of 5 constructs will be effective.
Cellecta makes the inserts, clones them, and sequences the constructs to verify correct construction. You receive several of the best-designed constructs to test and characterize to see which best matches your experimental needs. We can provide the plasmid constructs, or you have the option to also package the constructs as ready-to-transduce lentiviral particles.
This level cannot be guaranteed for any specific target, and the percentage of highly effective shRNAs will vary from target to target.
Choose the Vector
You can order the shRNA cloning in the standard DECIPHER vector or in a modified version. Browse Vector Options for vector information for standard cloning vectors, including shRNA cassettes and primer maps, sequences, GenBank files, and vector maps.
Fig.1. pRSI lentiviral shRNA expression vector.
Performance Data
Fig.2. Percentage knockdown for 120 shRNA constructs targeting 8 genes.
Related Service
Product Citations
- Camgoz A et al. (2018) STK3 is a therapeutic target for a subset of acute myeloid leukemias. Oncotarget. 2018 May 22, 9(39):25458-25473. PMID: 29876001
- di Gennaro A et al. (2018) A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness. Cell Death Differ. 2018 Apr 17. doi: 10.1038/s41418-018-0103-x. PMID: 29666469
- Heaton WL et al. (2018) Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion. Leukemia. 2018 Apr 18. doi: 10.1038/s41375-018-0131-z. PMID: 29749399
- Coots RA et al. (2017) m6A Facilitates eIF4F-Independent mRNA Translation. Mol Cell. 2017 Nov 2, 68(3):504-514.e7. PMID: 29107534
- Kedves AT1 et al. (2017) Recurrent ubiquitin B silencing in gynecological cancers establishes dependence on ubiquitin C. J Clin Invest. 2017 Dec 1, 127(12):4554-4568. PMID: 29130934
- Catalog Number
CVSHC-PX-CT - Supplier
Cellecta - Size
- Shipping
Blue Ice